Access Policy Tracking and Monitoring

Our policy tracking and monitoring services deliver timely, synthesized insights on policy developments that impact pricing, reimbursement, market access, and value-based procurement for innovative medical technologies in China.

While market access in developed economies, such as Europe and the US, is largely focused on pricing and meeting local requirements—like achieving the appropriate ICER threshold in the UK—China's approach is broader. The government prioritizes systemic reforms through the Tripartite System Reform (TSR), coordinating efforts across medical technology manufacturing, distribution, insurance, and healthcare providers. This reform aims to create a balanced system for Universal Health Coverage (UHC), addressing the diverse healthcare needs of the emerging middle class.

Given this unique landscape, our policy tracking services take a comprehensive approach. We begin by understanding your technology and identifying the specific policy areas that influence its pricing, reimbursement, and access. From there, we closely monitor relevant policy developments and provide timely, synthesized analysis delivered directly to your inbox in easy-to-digest PowerPoint summaries.